Doxycycline post-exposure prophylaxis: a primer for dermatologists
Doxycycline post-exposure prophylaxis (DoxyPEP) is an effective strategy to reduce bacterial sexually transmitted infections (STIs) in high-risk populations. With its 2024 endorsement by the CDC, DoxyPEP offers timely benefits amid rising STI rates, but its broader adoption raises concerns about antimicrobial resistance and potential side-effects. Dermatologists, with their extensive experience in prescribing doxycycline, are well positioned to educate patients, optimize its safe use and contribute to holistic sexual health prevention strategies.
Authors
- Emily Woolhiser (ORCID: https://orcid.org/0009-0000-2631-5551)
- John G. Zampella (ORCID: https://orcid.org/0000-0002-4886-4567)
- John Trinidad (ORCID: https://orcid.org/0000-0003-3508-4956)
- Jake Nusynowitz (ORCID: https://orcid.org/0000-0003-2667-2035)
- Sophia Manduca (ORCID: https://orcid.org/0009-0004-5298-6868)
Institutions
- Kansas City University (US)
- Florida International University (US)
- Massachusetts General Hospital (US)
- New York University (US)
Publication Details
- Journal
- British Journal of Dermatology
- Published
- 2025-02-22
- DOI
- https://doi.org/10.1093/bjd/ljaf069
- Citations
- 1
- Primary Topic
- Acne and Rosacea Treatments and Effects
- Type
- article
- Field-Weighted Citation Impact
- 2.00